Covalent organic frameworks

The first members of covalent organic frameworks (COF) have been designed and successfully synthesized by condensation reactions of phenyl diboronic acid C6H4[B(OH)2]2 and hexahydroxytriphenylene C18H6(OH)6. The high crystallinity of the products (C3H2BO)6 (C9H12)1 (COF-1) and C9H4BO2 (COF-5) has allowed definitive resolution of their structure by powder X-ray diffraction methods which reveal expanded porous graphitic layers that are either staggered (COF-1, P63/mmc) or eclipsed (COF-5, P6/mmm). They exhibit high thermal stability (to temperatures up to 500- to 600-C), permanent porosity, and high surface areas (711 and 1590 m2/g, respectively) surpassing those of related inorganic frameworks. A similar approach has been used for the design of other extended structures

Metal-organic and covalent organic frameworks (MOFs and COFs) as adsorbents for environmentally significant gases (H2, CO2, and CH4)

A series of metal-organic frameworks (MOFs) and covalent organic frameworks (COFs) possessing various functionalities, pore structures, and surface areas were evaluated for sorption and storage properties of environmentally significant gases (H_2, CO_2, and CH_4). It was concluded that the gas sorption behavior follows a general trend that materials with high surface area show enhanced gas uptake performance. For example, MOF-177 (SA = 5200 m^2/g) captures 7.2 wt% of H_2 at 77 K and 19 wt% of CH_4 at 298 K. In addition, MOF-177 exhibits exceptionally high gravimetric CO_2 uptake up to 120 wt% at 298 K. Similarly, the gas storage capacity for COFs seems to follow the same trend and it is determined by the apparent surface area. The architectural stability of both COFs and MOFs upon high pressure H_2 and CH_4 gas sorption measurements were manifested by isotherms which reach saturation without significant hysteresis

Designed Synthesis of 3D Covalent Organic Frameworks

Three-dimensional covalent organic frameworks (3D COFs) were synthesized by targeting two nets based on triangular and tetrahedral nodes: ctn and bor. The respective 3D COFs were synthesized as crystalline solids by condensation reactions of tetrahedral tetra(4-dihydroxyborylphenyl) methane or tetra(4-dihydroxyborylphenyl)silane and by co-condensation of triangular 2,3,6,7,10,11-hexahydroxytriphenylene. Because these materials are entirely constructed from strong covalent bonds (C-C, C-O, C-B, and B-O), they have high thermal stabilities (400° to 500°C), and they also have high surface areas (3472 and 4210 square meters per gram for COF-102 and COF-103, respectively) and extremely low densities (0.17 grams per cubic centimeter)

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

A conjugated plier-linked nano-spacing graphite network for sodium-ion battery

© 2021 Elsevier B.V. All rights reserved. A sodium-ion battery to use natural graphite is challenging due to the hard accessibility of sodium ions into graphite. Here, we report a plier-linked graphite network (PGN) with plier-like, conjugated active-molecule for sodium-ion battery anode. The newly designed PGN with conjugated linkers provides additional sodium-ion storage sites and sufficient nano-meter level wide two-dimensional spaces for sodium-ion access. The plier-linked graphite network (PDA-PGN) with 9,9-dihexylfluorene-2,7-diboronic acid (PDA) among variable linkers delivers the highest sodiation/desodiation capacity (298/245 mAh g(-1)), at approximately 10 times the level of graphite, while maintaining acceptable rate capability and stability, realizing 1.52 mAh cm(-2) areal capacity with high electrode thickness (282 mu m) and mass loading (7.8 mg cm(-2)). We revealed the knowledge of a major synergistic phenomenon between the conjugated PDA molecules and the nano-sized interlayer distance. Our PDA-PGN design added the new understanding to the alkali-metal ion storage and offers the production potential for low-cost and versatile electrodes.11Nsciescopu